UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (date of earliest event reported): August 24, 2020

Frequency Electronics, Inc.

(Exact name of registrant as specified in its charter)

55 Charles Lindbergh Blvd.,

Mitchel Field, New York 11553

(Address of principal executive offices, including zip code)

Registrant’s telephone number, including area code: (516) 794-4500

(Former name or former address, if changed since last report): Not Applicable

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 

On August 24, 2020, Joel Girsky delivered a letter to the Board of Directors (the “Board”) of Frequency Electronics, Inc. (the “Company”) informing the Board of his decision to resign from the Board effective immediately. Mr. Girsky was not a member of any committee of the Board at the time of his resignation.

In his resignation letter, a copy of which is attached as Exhibit 17.1 to this Current Report on Form 8-K, Mr. Girsky made statements regarding his disagreements with the Board and Company management on certain matters relating to the Company’s operations, policies and practices, including Mr. Girsky’s belief that the Board was excluding him from its decision making process. Mr. Girsky’s resignation letter also purports to describe certain events supporting his assertions. The Board and the Company strongly disagree with Mr. Girsky’s assertions, including as they relate to the complaint filed by Martin B. Bloch, the former Chief Scientist of the Company and a current member of the Board, against the Company and the other members of the Board (except for Mr. Girsky), which was previously disclosed on a Current Report on Form 8-K filed by the Company on January 31, 2020. The Company believes the proper forum to resolve the litigation with Mr. Bloch is through the pending proceedings, and therefore the Company will not include a detailed refutation of Mr. Girsky’s assertions in this Current Report on Form 8-K.

In accordance with the requirements of Item 5.02 of Form 8-K, the Company has provided Mr. Girsky with a copy of the disclosures contained in this Current Report on Form 8-K no later than the day on which the Company filed this Current Report on Form 8-K with the U.S. Securities and Exchange Commission.

On August 28, 2020, the independent directors of the Company issued a statement in response to Mr. Girsky’s resignation letter, a copy of which is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

The information contained in this Item 7.01 (including Exhibit 99.1) is being furnished and shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section and shall not be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

(d)      Exhibits

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: August 28, 2020

FREQUENCY ELECTRONICS, INC.

By:      /s/ Steven L. Bernstein          

Name: Steven L. Bernstein

Title:   Chief Financial Officer, Secretary and Treasurer

Exhibit 17.1

Joel Girsky 29 Winter Lane

Dix Hills, NY 11746

August 24, 2020

Delivered By Email

Board of Directors Frequency Electronics, Inc.

55 Charles Lindbergh Boulevard

Mitchel Field, New York 11553

Attention: Dr. Stanton Sloane, President and Chief Executive Officer

Gentlemen:

I have served on the Board of Directors (the “Board”) of Frequency Electronics, Inc. (the “Company”) for more than thirty years, including service as Chairman of the Board and, until very recently, Chairman of the Audit Committee of the Board. Pursuant to Section 141(b) of the Delaware General Corporation Law and Section 2.2 of the Amended and Restated Bylaws of the Company, I hereby resign from the Board of Directors of the Company, effective immediately. If and to the extent that I hold any other positions with the Company or any of its subsidiaries, I hereby resign those positions, too.

With specific reference to Items 5.02(a)(1) and 5.02(a)(2) of SEC Form 8-K and as my statement of the circumstances surrounding this resignation, I wish to note for the record several disagreements that I have with the Company, as directed by the incumbent Board majority and current management, on matters relating to the Company’s operations, policies and practices.

Among other things, my disagreements relate to the following:

●       The Company has adopted a policy and practice of depriving me, a director, of information necessary to exercise legally required, effective oversight of management. Beginning with the Company’s decision to terminate its founder and Chief Scientist, Martin Bloch, Board meetings have been Kabuki theatre in contrast to the fully- informed decision-making sessions required by state law, the Sarbanes-Oxley Act and Nasdaq rules. Board actions have been pre-ordained; relevant information has been withheld as information requests have been ignored; responses to information inquiries have been slow-walked when not summarily denied; and Board meetings themselves have been rushed, pro forma, check-the-box processes, without more. The Board majority will listen no longer to opposing points of view in Board meetings, or between meetings, and has instead abdicated its responsibilities and its judgment to the Company’s regular outside legal counsel. This is not good governance. It is the Good Old Boys Club echo chamber that the federal Sarbanes-Oxley Act was enacted to end. For a few examples of the defective policy and practice in action, consider these:

●       The Board majority misinterpreted “disagreement” as “disloyalty” and set upon a course of conduct which stifled dissent and which makes it impossible for an individual to exercise independent judgment as a member of the Board. You asserted that I was disloyal to the Company because I wouldn’t fall into line as you fired the Company’s founder and were sued by him for that. I will continue to tell the truth about your rush to judgment against Martin Bloch. Knowing that I won’t capitulate to your strong-arm tactics, you decided to freeze me out of your processes and decisions, ignoring the fact that I, too, am a director of the Company, charged with exercising independent judgment after developing a record of all the relevant facts and entitled to unfettered, unfiltered access to relevant information.

●       With reference to Martin Bloch and the Company’s on-going dispute with him, I advocated working out issues, a cost-benefit analysis, and reaching for a consensus, but the Board majority rushed to judgment and picked a fight. The Board majority refused to provide additional time for a fair process in considering Bloch’s termination, which in my view would have avoided the expensive, risky disputes with Bloch in which the Company is now immersed. The law firm that recommended the approach adopted by the Board majority is now defending the Company in the Bloch litigation and arbitrations, earning significant additional fees in the process. Its conflict of interest is obvious.

●       Although you’ve gone to mere “check-the-box” corporate governance, sometimes you don’t even bother to check the box. I was informed that I had been voted off the Audit Committee (of which I was Chairman) when in July the Board re- staffed its Committees and dropped me from all of them. But that is not what happened. I attended that Board meeting. While re-staffing was mentioned in pre-meeting materials, at the Board meeting not only was there no discussion of Board committees or their work; there was no mention of Board committee staffing, either. This is no way to run a board of directors. The Board should discuss the candidates for Committee positions before voting on them irrespective of any pre-meeting agenda. Regardless of that, the Board should be asked expressly to vote on the matter. Assent to an agenda cannot lawfully be presumed from the mere existence of the agenda.

●       A possible change of control, and stock purchases and awards, are not being discussed in Board meetings as would be correct. There have been conversations among some directors about taking the Company private. This has no obvious relationship with the Bloch disputes, as to which the Board majority asserts that I am conflicted and that they are not conflicted, despite capital gains which some might realize in a buy-out, especially if the Company’s obligations to Bloch are terminated. Nevertheless, I have been largely excluded from those conversations. I believe that at least one of the directors has been purchasing Company stock through affiliates during this same time period. These purchases were not vetted in any Board meeting in which I was present, and I have attended every Board meeting in the last year. I also believe that the CEO has bought additional shares recently.

●       The Company’s emerging pattern and practice of discriminating against employees and directors by reason of their age is worrisome. Mr. Bloch was the oldest employee and director of the Company when he was terminated. Only Bloch and one other director are older than me as I submit this resignation, having been ostracized since my dissent from Bloch’s hasty termination. I am aware of at least two pending lawsuits and/or EEOC claims, apart from the Bloch disputes, that have been filed recently against the Company by long-serving employees, each alleging age-based employment discrimination. The second of these claims was not identified to me as a director but uncovered by other means. I have no idea how many other claims have been threatened or made. The emerging pattern and practice has not been discussed in a Board meeting, which is worrisome.

I submit my resignation knowing that the Board and its regular outside counsel are obstinate in their views and will not change because of my disagreements. In fact, my on-going efforts to obtain necessary information to discharge my duties as an independent director and to otherwise resolve the matters described above have been rejected summarily by the Company. Like Pharaoh, you have made up your mind despite all evidence to the contrary. Like Pharaoh, you will be unmoved by this.

As a fiduciary resigning my position, I believe that an investigation into these matters is warranted in the interest of the Company’s public stockholders. In view of the obvious bias of the incumbent Board and its regular outside counsel, evidenced by the treatment given me (and summarized above) ever since I dissented from the Board’s decision (advised by such counsel) to terminate Mr. Bloch, that investigation should be conducted by a law firm having no relationship with the Company or with any of its directors or officers, if not by the SEC, the New York Investor Protection Bureau or Nasdaq. I can be reached at my address, stated above, or by telephone at (631) 423-5130, if there is a sense that I can be helpful in such an investigation.

Sincerely,

/s/ Joel Girsky

Exhibit 99.1

Statement of the Independent Directors of Frequency Electronics, Inc.

On August 28, 2020, the independent directors of Frequency Electronics, Inc., a Delaware corporation, issued the following statement in response to the resignation letter of Joel Girsky:

The undersigned independent directors of Frequency Electronics, Inc., strongly disagree with Mr. Girsky’s assertions, which we believe are false, misleading, and defamatory of the Company’s directors, officers, and representatives. The undersigned include two directors whose affiliates collectively own approximately 23.4% of the company’s outstanding shares, a director identified and initially nominated to the Board of Directors by an investor, and a director who has been on the Board of Directors with Messrs. Girsky and Bloch for approximately 16 years. Mr. Girsky’s resignation letter was received days after Mr. Girsky learned that he was not being re-nominated to stand for election at the company’s annual stockholders meeting.

Russell Sarachek, Non-executive Chairman of the Board

Jonathan Brolin

General Lance Lord, USAF (retired)

Richard Schwartz